Media
VC ‘Unstealthing’ Strategy Requires Strong Marketing
by Laurie Sullivan @lauriesullivan, January 15, 2024 The marketing industry may get a boost this year, but not the way […]
Read More
Science-Driven VC Fund, Harmonix – VC10X – Venture Capital Podcast
We have Maximilian Winter, General Partner & Krish Ramadurai, Partner at Harmonix fund with us. Harmonix invests in technological breakthroughs […]
Read More2024 set to be a better year for VCs in Asia — but not by much
Japan and India set to benefit from Sino-U.S. tensions but China still leads Employees of a VC firm in Japan. […]
Read MoreThe Unsung Tech Sectors of 2023
Good day. Last week we asked about the most underappreciated tech sectors for startups in 2023. Here are some responses, […]
Read More
Could AI plan buoy Israel’s floundering hi-tech?
HI-TECH AFFAIRS: The hi-tech turmoil gripping Israel’sonce-thriving ecosystem is the result of several challenges thathave converged to cause trouble for […]
Read MoreLeading VC Partner: ‘Investors today want to see profit, not just ideas’
Today’s investment landscape has become a much more profitability-driven environment, says US-based Harmonix Ventures partner Krish Ramadurai. By ZACHY HENNESSEY OCTOBER […]
Read More
China’s venture capital firms making inroads in Saudi Arabia, UAE
Chinese venture capital investors have been pricing deals at more competitive rates and taking advantage of a widening vacuum left […]
Read MoreHarmonix: A Venture Firm Investing In Data-Driven Healthcare And Life Science Companies
Harmonix is a venture capital firm that is investing in data-driven platform companies at the nexus of healthcare, life sciences, […]
Read MoreHow one biotech VC is shooting for the moon and beyond
Harmonix typically funds anywhere from $500,000 to $5 million. “The best way to predict the future is to invent it.” […]
Read MoreA German Family Dynasty – from Foundries to Outer Space
By James Williams 17th August 2023 Maximilian Winter, the grandson of Fritz Winter, who founded one of Germany’s biggest foundries […]
Read MoreWhy VCs are Investing in Value-Based Care
The US may never move to a fully value-based system, but venture capitalists still think it’s worth investing in. By […]
Read More‘Asia presents potential for high-impact,high-return investments in life sciences,deeptech’
Yet, there're unique challenges to investing in Asia, such as its complex regulatory environment and cultural and language differences: says Harmonix's Maximilian Winter
Read MoreHarmonix, backer of science-driven startups, launches third fund
Harmonix is currently trying to raise capital for its third fund, having recently closed a modest “roughly $20 million” second fund. The La Quinta, California-based firm invests in life sciences, healthcare, and deep-tech infrastructure companies primarily based in the US.
Read More
Harmonix unveils third healthcare and deep tech fund
Fund III will support start-ups advancing engineering and scientific breakthroughs.
Read More
Biomedical Investor Harmonix Raising Two New Venture Funds
Biomedical investor Harmonix’s story is different from other venture firms, which often get their start by raising a small first-time fund from backers.
Read MoreHow family offices are at the forefront of health care investing
Like many family office members who have funded health care, it was personal for Maximilian Winter. The scion of a German family that made its fortune in the automotive industry, Winter came down with Lyme disease about 10 years ago.
Read MoreSpace investing: Europe’s growing space sector
Annual investment in Europe’s space industry has surpassed that of its United States counterpart. Benjamin David examines what this means for the […]
Read More
VC Firm Harmonix Fund Pioneers Breakthroughs in Life Sciences, Healthcare, and Deep Tech
In a world that’s continually moving towards breakthrough technologies, Harmonix Fund stands at the forefront, carving out a niche for […]
Read More